Fetal gene therapy of α-thalassemia in a mouse model

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2007-05-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0702457104PMCID PMC1885618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Successful treatment of UGT1A1 deficiency in a rat model of Crigler-Najjar disease by intravenous administration of a liver-specific lentiviral vector.

  2006cited by this paper
• A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference

  2006cited by this paper
• Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease

  2004cited by this paper
• Highly efficient EIAV-mediated in utero gene transfer and expression in the major muscle groups affected by Duchenne muscular dystrophy

  2004cited by this paper
• Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer.

  2003cited by this paper
• A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.

  2003cited by this paper
• Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice

  2003cited by this paper
• Homozygous α-thalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation

  2003cited by this paper
• Successful treatment of murine β-thalassemia intermedia by transfer of the human β-globin gene

  2002cited by this paper
• Successful mismatched sibling cord blood transplant in Hb Bart's disease

  2001cited by this paper
• Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy

  2001cited by this paper
• Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin

  2000cited by this paper
• Human Cord Blood CD34+CD38- Cell Transduction via Lentivirus-Based Gene Transfer Vectors

  1999cited by this paper
• Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer

  1999cited by this paper
• Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

  1999cited by this paper
• Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.

  1999cited by this paper
• HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells.

  1998cited by this paper
• Treatment of hemoglobin Bart's hydrops with bone marrow transplantation.

  1998cited by this paper
• Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

  1997cited by this paper
• Origin and fate of the central macrophages of erythroblastic islands in the fetal and neonatal mouse liver

  1997cited by this paper
• A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.

  1996cited by this paper
• Inactivation of mouse alpha-globin gene by homologous recombination: mouse model of hemoglobin H disease.

  1996cited by this paper
• Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

  1996cited by this paper
• Human alpha-globin genes demonstrate autonomous developmental regulation in transgenic mice

  1991cited by this paper
• Survival of a hydropic infant with homozygous α-thalassemia-1

  1986cited by this paper
• Normal long-term survival with α-thalassemia

  1986cited by this paper
• Prenatal diagnosis of α-thalassemia: clinical application of molecular hybridization.

  1976cited by this paper
• Ontogeny of the Haemopoietic System: Yolk Sac Origin of In Vivo and In Vitro Colony Forming Cells in the Developing Mouse Embryo *

  1970cited by this paper

• Lentiviral vectors for gene therapy of α-thalassemia

  2025cites this paper
• Opportunities and Challenges of Fetal Gene Therapy

  2025cites this paper
• In Utero Stem Cell Transplantation, Enzyme Replacement, and Gene Therapy

  2021cites this paper
• Gene Therapy: Principles and Clinical Potential

  2019cites this paper
• A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model

  2018cites this paper
• In Utero Gene Therapy and Genome Editing

  2018cites this paper
• Perinatal Gene Therapy

  2016cites this paper
• Chapter 12 – Gene Therapy for Hemoglobinopathies: Progress and Challenges

  2015cites this paper
• Hemoglobinopatilerde Genetik Modifiye Hematopoetik Kök Hücre Tedavisi Gene-Modified Hematopoietic Stem Cell Therapy for Hemoglobinopathies

  2014cites this paper
• Gene therapy for hemoglobinopathies: progress and challenges.

  2013cites this paper
• Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia

  2013cites this paper
• Zinc-finger nuclease-mediated correction of α-thalassemia in iPS cells.

  2012cites this paper
• Candidate diseases for prenatal gene therapy.

  2012cites this paper
• Fetal gene therapy: recent advances and current challenges

  2011cites this paper
• Recent advances in fetal gene therapy.

  2011cites this paper
• Regulatory and Ethical Issues for Phase I In Utero Gene Transfer Studies

  2011cites this paper
• Organ targeted prenatal gene therapy—how far are we?

  2011cites this paper
• In utero gene delivery using chitosan-DNA nanoparticles in mice.

  2011cites this paper
• Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene

  2010cites this paper
• IN UTERO GENE DELIVERY OF AAV VECTORS FOR EFFICIENT TREATMENT OF MUSCLE DISORDERS

  2010cites this paper
• Perinatal Stem Cell Therapy

  2010cites this paper
• In Utero Muscle Gene Transfer

  2010cites this paper
• Prenatal gene therapy for the early treatment of genetic disorders

  2009cites this paper
• Was cDNA sequences modulate transgene expression of was promoter-driven lentiviral vectors.

  2009cites this paper
• Fetal gene therapy: opportunities and risks.

  2009cites this paper
• Gene Therapy in Thalassemia and Hemoglobinopathies

  2009cites this paper
• Chapter 2 In Utero Muscle Gene Transfer

  2009cites this paper
• An overview on the study of gene therapy of hemoglobin disorders

  2009cites this paper
• Investigation of gene and cellular therapies to cure maple syrup urine disease (MSUD) in a genetically engineered mouse model

  2008cites this paper
• Hematopoietic cell transplantation for hemoglobinopathies.

  2008cites this paper
• Perinatal stem-cell and gene therapy for hemoglobinopathies.

  2008cites this paper
• Restricted transgene persistence after lentiviral vector‐mediated fetal gene transfer in the pregnant rabbit model

  2008cites this paper